BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29545720)

  • 1. Prognostic factors of primary gastrointestinal stromal tumors: a cohort study based on high-volume centers.
    Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
    Chin J Cancer Res; 2018 Feb; 30(1):61-71. PubMed ID: 29545720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of prognostic factors of primary small intestinal gastrointestinal stromal tumors with R0 resection: A single-center retrospective study.
    Qu H; Xu Z; Ren Y; Gong Z; Ju RH; Zhang F; Shao S; Chen X; Chen X
    Medicine (Baltimore); 2022 Jun; 101(25):e29487. PubMed ID: 35758385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of gastric gastrointestinal stromal tumors in Shandong Province: a midterm report of multicenter GISSG1201 study].
    Hou Q; Luo W; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Guo H; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1025-1030. PubMed ID: 28900994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
    Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
    Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade.
    Hasegawa T; Matsuno Y; Shimoda T; Hirohashi S
    Hum Pathol; 2002 Jun; 33(6):669-76. PubMed ID: 12152168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
    Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
    Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor.
    Liu X; Lin E; Sun Y; Liu X; Li Z; Jiao X; Li Y; Guo D; Zhang P; Feng X; Chen T; Niu Z; Zhou Z; Qiu H; Zhou Y
    Front Med (Lausanne); 2022; 9():777181. PubMed ID: 35360729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
    Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
    Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
    Wang Y; Chen JJ; Wang XF; Wang Q
    World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
    Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
    Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
    BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors.
    Tai WC; Chuah SK; Lin JW; Chen HH; Huang HY; Kuo CM; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Nov; 20(5):1157-64. PubMed ID: 18949416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib therapy after resection of high-risk gastrointestinal stromal tumors in Chinese patients: a median follow-up of 48 months.
    Lei C; Zhao B; Wang Q; Ge L; Wang H
    J BUON; 2018; 23(2):460-467. PubMed ID: 29745093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon.
    Zhou Z; Chen Z; Chen M; Wang R; Yin Y; Yao Y
    Tumour Biol; 2014 May; 35(5):4357-62. PubMed ID: 24375257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumor.
    Quek R; Farid M; Kanjanapan Y; Lim C; Tan IB; Kesavan S; Lim TKH; Oon LL; Goh BK; Chan WH; Teo M; Chung AY; Ong HS; Wong WK; Tan P; Yip D
    Asia Pac J Clin Oncol; 2017 Jun; 13(3):115-124. PubMed ID: 27753268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of clinical features and prognostic factors on reoperation patients with postoperative recurrence or metastasis of gastrointestinal stromal tumor].
    Wang L; Xu W; Yao X; Yan C; Li C; Zhu Z; Liu W; Yan M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1274-1279. PubMed ID: 30506539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.